Cargando…
Immunological Networks Defining the Heterogeneity of Inflammatory Bowel Diseases
Current practice in IBD is to classify patients based on clinical signs and symptoms and provide treatments accordingly. However, the response of IBD patients to available treatments is highly variable, highlighting clinically significant heterogeneity among patients. Thus, more accurate patient str...
Autores principales: | Selin, Katja A, Hedin, Charlotte R H, Villablanca, Eduardo J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575046/ https://www.ncbi.nlm.nih.gov/pubmed/33959743 http://dx.doi.org/10.1093/ecco-jcc/jjab085 |
Ejemplares similares
-
Type 2 immunity in intestinal homeostasis and inflammatory bowel disease
por: Luo, Xinxin, et al.
Publicado: (2021) -
The Immunological Basis of Inflammatory Bowel Disease
por: Silva, Francesca A. R., et al.
Publicado: (2016) -
Immunological pathogenesis of inflammatory bowel disease
por: Lee, Seung Hoon, et al.
Publicado: (2018) -
Immunology of Inflammatory Bowel Disease: Molecular Mechanisms and Therapeutics
por: Lu, Quan, et al.
Publicado: (2022) -
Adipokine-Modulated Immunological Homeostasis Shapes the Pathophysiology of Inflammatory Bowel Disease
por: Tsai, Yi-Wen, et al.
Publicado: (2020)